About Vortex Biosciences
Vortex Biosciences is a company based in Menlo Park (United States) founded in 2012 was acquired by EMV Capital in March 2019.. Vortex Biosciences has raised $4.08 million across 2 funding rounds from investors including EMV Capital and EMV Capital. Vortex Biosciences offers products and services including VTX-1 Liquid Biopsy System. Vortex Biosciences operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vortex Biosciences Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.08 M (USD)
in 2 rounds
-
Latest Funding Round
$4.08 M (USD), Seed
Jun 22, 2023
-
Investors
EMV Capital
& 1 more
-
Employee Count
Employee Count
-
Acquired by
EMV Capital
(Mar 25, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vortex Biosciences
Vortex Biosciences offers a comprehensive portfolio of products and services, including VTX-1 Liquid Biopsy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates capture of circulating tumor cells from blood for research.
Unlock access to complete
Unlock access to complete
Chairman Team
1 people
Advisor Team
1 people
Leadership Team
1 people
Operations Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Vortex Biosciences
Vortex Biosciences has successfully raised a total of $4.08M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $4.08 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $4.1M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Seed - Vortex Biosciences | Valuation | EMV Capital | |
| May, 2022 | Amount | Seed - Vortex Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vortex Biosciences
Vortex Biosciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include EMV Capital and EMV Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B2B-tech focused VC firm
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in deep tech and life sciences by EMV Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vortex Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vortex Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vortex Biosciences Comparisons
Competitors of Vortex Biosciences
Vortex Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vortex Biosciences
Frequently Asked Questions about Vortex Biosciences
When was Vortex Biosciences founded?
Vortex Biosciences was founded in 2012 and raised its 1st funding round 10 years after it was founded.
Where is Vortex Biosciences located?
Vortex Biosciences is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Vortex Biosciences a funded company?
Vortex Biosciences is a funded company, having raised a total of $4.08M across 2 funding rounds to date.
What does Vortex Biosciences do?
Vortex Biosciences was founded in 2012 in Menlo Park, United States, within the biotechnology sector focused on diagnostics. A liquid biopsy system known as VTX-1 is offered to automate the isolation and collection of circulating tumor cells from blood samples. These cells are released from reservoirs and gathered downstream for additional assays in clinical applications. Operations center on enabling further analysis of tumor cells for medical diagnostics.
Who are the top competitors of Vortex Biosciences?
Vortex Biosciences's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Vortex Biosciences offer?
Vortex Biosciences offers VTX-1 Liquid Biopsy System.
Who are Vortex Biosciences's investors?
Vortex Biosciences has 2 investors. Key investors include EMV Capital, and EMV Capital.